&w=3840&q=100)
War against cancer: A victory in progress as death rates tumble with new drugs, screening and prevention
The fight against cancer has been yielding results slowly and steadily. Data on cancer's manifestations and treatment has painted a positive picture. Could that mean that the world is inching closer to a cure?
While an answer to that remains uncertain, other factors, like death rates and advanced medical treatment, suggest that things are looking better than they were a decade ago.
Here's how:
Falling death rates
The chances of getting affected by cancer increase as people age. Since the 1990s, the age-adjusted death rate related to cancer has fallen considerably. For example, in the US, where cancer is the second-most common cause of death, the age-adjusted death rate is now a third lower than in the 1990s. This trend is not exclusive to America, but is mimicked by other developed countries as well.
A 2024 report by the Nation on the Status of Cancer shows that overall death rates from cancer declined steadily among both men and women from 2001 through 2022, even during the first two years of the Covid-19 pandemic.
STORY CONTINUES BELOW THIS AD
Childhood leukaemia survival rates go up
The survival rate of childhood leukaemia has increased significantly in the past few years. Now, it has a five-year survival rate above 90 per cent. This has been made possible by advancements in treatment measures for Acute Lymphoblastic Leukaemia (ALL), which is the most common type that affects children.
Better prevention
One of the most overlooked success stories in the fight against cancer is prevention. For instance, smoking rates have dropped sharply in high-income countries, likely preventing over 3 million cancer deaths in the US alone since 1975.
Yet smoking still accounts for one in five cancer deaths globally. This means that anti-tobacco efforts in low- and middle-income countries, where smoking remains widespread, have the potential to save millions more lives.
Cheaper treatment
Cancer treatment has gone easy on the pockets considerably. Curbing the spread of cervical cancer, the most common cancer among women, is a case in point. Cervical cancer is caused by the delayed side-effect of infection with the human papillomavirus (HPV).
Now, the prevalence of the HPV vaccine and its administration to young girls across the world has brought down the chances of getting the bug at all.
In the UK, for example, HPV vaccines have brought down the rates of cervical cancer among women in their 20s are down by 90 per cent.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
12 minutes ago
- Indian Express
GMCH-32: Newly constructed block to be inaugurated on Aug 8, to decongest gynaecology dept
The newly constructed 283-bed Emergency-cum-Trauma Block at GMCH-32 is all set to be inaugurated on August 8, to coincide with the 11th convocation, promising to reduce overload on the existing emergency units in the city, improve patient care and ensure better utilisation of resources. In the hospital's history, the A Block, where 24-hour emergency services are provided to patients, was the first to become functional, and since 1996, there has been no renovation of this block. 'With the new state-of-the-art trauma block ready for patients, the first step will be to renovate the area, with the engineering and fire safety departments already in action to ensure the latest facilities, amenities and safety. Once this is complete, we will start the process of decongesting our gynaecology department, which also comprises the labour room, and witnesses patients from across the region, including the large migrant population that we have. We will be utilising this space for the expansion of the department, and also add more beds to ease rush. We are making efforts to provide more speciality and super-speciality services. The process of space creation is a dynamic one,' said Prof A K Attri, Director-Principal, GMCH-32. The gynaecology department of the hospital has 100 beds, with 10 beds added way back in 2017. The number of patients in the gynaecology department is very high, and despite the increase in beds, there are not enough beds for pregnant women. More than 5,000 women deliver in GMCH every year, and when the number of cases is higher, two women have to be adjusted on one bed, with the occupancy rate almost 200 per cent. The hospital receives delivery cases from Chandigarh, Punjab, Haryana, Himachal, Uttarakhand, UP, and despite the shortage of beds, the effort is to provide treatment. As per doctors, the gynaecology department of GMCH-32 has the highest number of deliveries, followed by GMSH-16 and then PGI. Both PGI and GMCH-32 will have exclusive Mother and Child Centres, with work on the project of GMCH-32 having started in 2018, but was delayed due to COVID and has now restarted. With a budget of about Rs 73 crore, the centre, which will be open in about two years, will have two basements and four floors and have a facility of 251 beds, with the latest facilities and services under one roof. Dr Attri said it will decrease infant and mother mortality rate. PGI's Advanced Mother and Child Care Centre, where work is in full swing and may be inaugurated at the end of this year, will be equipped with the latest technologies and offer world-class facilities in both maternal and neonatal care. A human milk bank, advanced infertility treatment, robotic surgery, critical care obstetrics, high-risk maternity unit, foetal medicine unit, pre-implantation genetic diagnosis, prenatal diagnosis, and reproductive endocrinology unit will be part of the centre. Here, there will be a modern developmentally supportive and family-centred level IV NICU designed as per current International NICU design specifications, a family-centred Kangaroo Mother Care ward, and a comprehensive high-risk follow-up programme. A long-needed facility, the Advanced Paediatric Centre at GMSH-16 was inaugurated last year. The 32-bedded facility offers state-of-the-art specialised care, featuring a 12-bedded hybrid ICU unit comprising ventilator beds and high-dependency unit beds. The centre includes 20 oxygen-supported beds and features ECG, echocardiography, and ultrasonography, all under one roof, so that parents don't have to go anywhere for these tests and their children receive the best care. There are 24-hour services like blood transfusion, sample collection, nebulisation etc, for critical patients, and this advanced centre has eased the burden on PGI.
Time of India
8 hours ago
- Time of India
AIOCD demands strict action against illegal e-pharmacies; raises alarm over inaction by SLAs
The All-India Organisation of Chemists and Druggists ( AIOCD ), representing over 12.40 lakh chemists across India, has expressed grave concern over the illegal and unregulated operation of online pharmacy platforms, which allegedly continue to sell medicines in violation of the Drugs & Cosmetics Act, 1940, posing a serious threat to public health . Accoridng to a statement from AIOCD, JS Shinde, President, Rajiv Singhal, General Secretary, informed that in a formal communication addressed to the Minister of State for Health and Family Welfare, Anupriya Patel, AIOCD has highlighted the continued inaction by State Licensing Authorities (SLAs), despite repeated complaints being forwarded to them by the Central Drugs Standard Control Organisation ( CDSCO ). Explore courses from Top Institutes in Please select course: Select a Course Category Degree PGDM Operations Management MCA Data Science CXO healthcare MBA Technology Management Data Science Project Management Healthcare Cybersecurity Finance Data Analytics Leadership Design Thinking Others Artificial Intelligence others Digital Marketing Product Management Public Policy Skills you'll gain: Data-Driven Decision-Making Strategic Leadership and Transformation Global Business Acumen Comprehensive Business Expertise Duration: 2 Years University of Western Australia UWA Global MBA Starts on Jun 28, 2024 Get Details While the Minister's reply in the Rajya Sabha on 22nd July 2025 stated that complaints regarding unauthorised sale of medicines are referred to SLAs, however, AIOCD has informed that no visible or effective action has been taken by any SLA across the country. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo To escalate this matter further, a high-level delegation of AIOCD met with the Drug Controller General of India (DCGI), Dr Rajeev Raghuvanshi, on July 21, and urged him to take the following urgent actions: Immediate crackdown on all illegal e-pharmacies operating without any valid license or oversight, including the Quick Commerce Players; Withdrawal of GSR 220(E), which was issued during the COVID-19 epidemic but is now being misused by these platforms to justify unlawful activities, and Withdrawal of GSR 817(E), the draft regulation issued in August 2018, which has remained in draft form for over eight years, enabling misuse due to lack of legal clarity, according to the statement. AIOCD has repeatedly submitted that GSR 817(E) is outdated and has failed to address the ground realities of digital drug distribution. Live Events JS Shinde, President, Rajiv Singhal, General Secretary, AIOCD, highlighted that the loosely drafted definition of 'Manufacturer' is the root cause of the issue and emphasised the need for a holistic and comprehensive approach involving all concerned departments, the statement said. AIOCD also expressed its readiness to provide suitable amendments to the Act, Rules, and relevant orders. AIOCD reiterated that medicines are not ordinary consumer goods, and their sale and distribution must not be left to automated platforms or unauthorized logistics chains. Continued inaction will lead to a public health disaster of irreversible scale. According to the statement, AIOCD demanded immediate withdrawal of GSR 817(E) and GSR 220(E) to prevent further legal misuse; Centralized enforcement action by CDSCO against all illegal online pharmacies; Action of all illegal E pharmacies on government directives must be initiated immediately by State SLA's . AIOCD appeals to the Ministry of Health and Family Welfare to take urgent action in the interest of safeguarding public health and restoring trust in India's pharmaceutical regulatory system, the statement added.
New Indian Express
8 hours ago
- New Indian Express
Hyderabad to get disease surveillance unit soon to boost epidemic preparedness
HYDERABAD: A Metropolitan Surveillance Unit (MSU), a special facility equipped to monitor and analyse disease patterns in urban areas, is set to become operational in Hyderabad within the next two months. Approved by the Ministry of Health and Family Welfare (MoH&FW) under the National Centre for Disease Control (NCDC), the MSU will enhance the city's preparedness for disease outbreaks, drawing from lessons learned during the Covid-19 pandemic. The MSU will function as a specialised disease surveillance hub, conducting advanced diagnostic testing for communicable diseases and issuing alerts for potential outbreaks. It will not handle routine lab testing but will focus on diseases listed under the Integrated Disease Surveillance Programme (IDSP), including anthrax, chickenpox, diphtheria, measles, meningitis, mumps, pertussis, Ebola, Zika, Nipah and yellow fever, among others. GHMC officials told TNIE that the MSU will serve as a crucial node for surveillance, early warning and rapid response to outbreaks. 'The objective is to strengthen urban public health systems by enabling data-driven action. MSUs will be the first line of defence in identifying and containing future epidemics,' they said.
